Bausch Health Companies Inc. (BHC) is listed on NYSE in Pharmaceutical Stocks. It is $6.33, +0.48%, with a $2.4B market cap. RSI is 57.0, neutral. The latest reported quarter beat estimates. Insiders were net buyers across the listed trades.
Technical Analysis
RSI (14) 57.0 Neutral
Market Cap $2.4B
Volume 970.6K
Fundamentals — 10-Q Q2 2026
Revenue $5.4B
Net Income $-1.2B
EPS $-3.12
Operating Margin -3.9%
Net Margin -21.7%
Debt / Equity -11.7x
P/E Ratio -2.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Lenar Aimee J. | President, US Pharma | Sell | 36,827 | $7.03 | $258,894 | 2026 Aug 19 |
| Lee Frank D. | Director | Sell | 24,456 | $5.43 | $132,796 | 2026 May 19 |
| Carson Seana | EVP, General Counsel | Sell | 11,276 | $5.78 | $65,131 | 2026 Mar 3 |
| Carson Seana | EVP, General Counsel | Sell | 8,388 | $5.95 | $49,909 | 2026 Feb 27 |
| Paulson & Co. Inc. | 10% Owner | Buy | 2,500,000 | $6.25 | $15.6M | 2025 Nov 25 |
| Carson Seana | EVP, General Counsel | Sell | 13,370 | $7.31 | $97,735 | 2025 Sep 8 |
| Lee Frank D. | Director | Sell | 15,912 | $7.66 | $121,886 | 2025 Aug 21 |
| Paulson John | Director | Buy | 34,721,118 | $9.00 | $312.5M | 2025 Aug 14 |
| Paulson John | Director | Buy | 3,243,049 | $6.56 | $21.3M | 2025 Aug 13 |
| Paulson John | Director | Buy | 3,564,059 | $5.94 | $21.2M | 2025 Jun 13 |
| Paulson John | Director | Buy | 2,788,608 | $5.27 | $14.7M | 2025 Jun 12 |
| Carson Seana | EVP, General Counsel | Sell | 440 | $8.35 | $3,674 | 2024 Dec 2 |
| Carson Seana | EVP, General Counsel | Sell | 13,370 | $6.21 | $83,028 | 2024 Sep 6 |
| Carson Seana | EVP, General Counsel | Sell | 6,313 | $9.80 | $61,867 | 2024 Mar 4 |
| Carson Seana | EVP, General Counsel | Sell | 220 | $7.38 | $1,624 | 2023 Dec 5 |
| Carson Seana | EVP, General Counsel | Sell | 43 | $7.61 | $327 | 2023 Nov 6 |
| Carson Seana | EVP, General Counsel | Sell | 6,685 | $8.28 | $55,352 | 2023 Sep 6 |
| Carson Seana | EVP, General Counsel | Sell | 292 | $9.32 | $2,721 | 2023 Feb 28 |
| Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $22.19 | $35,393 | 2022 Apr 14 |
| Spurr Robert | U.S. President-Pharma Business | Sell | 4,846 | $22.20 | $107,581 | 2022 Mar 15 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
Take BHC further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BHC in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Bausch Health Companies Inc. next reports.
Set alerts on BHC
Get notified when Bausch Health Companies Inc. hits your price targets or technical conditions are met.
Get Started Free